US EditionPublished • loading... • Updated
Neuphoria Therapeutics Inc. Sends Letter to Stockholders - Neuphoria Therapeutics (NASDAQ:NEUP)
Summary by Benzinga
1 Articles
1 Articles
Neuphoria Therapeutics Inc. Sends Letter to Stockholders - Neuphoria Therapeutics (NASDAQ:NEUP)
Files Definitive Proxy Statement for 2025 Annual Meeting of Stockholders Urges Stockholders to Vote "FOR" BOTH Neuphoria Therapeutics Nominees on WHITE Proxy Card BURLINGTON, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. ("Neuphoria" or the "Company"), a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders, today issued a…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
